Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Mark Soloway

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Procedures

Concepts & Ideas

Neoplasm Staging

Chemicals & Drugs

Anatomy

Urinary Bladder

Living Beings

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
43
Manoharan, Murugesan
32
Civantos, Francisco
23
Ciancio, Gaetano
20
Kim, Sandy
19
Lokeshwar, Vinata
18
Nieder, Alan
17
Gomez, Pablo
13
Block, Norman
13
Sarosdy, Michael
11
Schellhammer, Paul
9
Sved, Paul
9
Obek, C
9
Chodak, Gerald
9
Ayyathurai, Rajinikanth
9
Duncan, Robert

Sign-in to see all Coauthors

Publications

TOP 3
Manoharan Murugesan; Ayyathurai Rajinikanth; Soloway Mark S
Radical cystectomy for urothelial carcinoma of the bladder: an analysis of perioperative and survival outcome.
Soloway Mark S
Editorial comment.
Gomez Christopher S; Gomez Pablo; Knapp Judith; Jorda Merce; Soloway Mark S; Lokeshwar Vinata B
Hyaluronic acid and HYAL-1 in prostate biopsy specimens: predictors of biochemical recurrence.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Mark Soloway (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Manoharan Murugesan; Ayyathurai Rajinikanth; Soloway Mark S
Radical cystectomy for urothelial carcinoma of the bladder: an analysis of perioperative and survival outcome.
BJU international 2009;104(9):1227-32.
2009: Soloway Mark S
Editorial comment.
Urology 2009;74(4):871-2; author reply 872.
2009: Gomez Christopher S; Gomez Pablo; Knapp Judith; Jorda Merce; Soloway Mark S; Lokeshwar Vinata B
Hyaluronic acid and HYAL-1 in prostate biopsy specimens: predictors of biochemical recurrence.
The Journal of urology 2009;182(4):1350-6.
2009: Shirodkar Samir P; Ciancio Gaetano; Soloway Mark S
Vascular stapling of the inferior vena cava: further refinement of techniques for the excision of extensive renal cell carcinoma with unresectable vena-caval involvement.
Urology 2009;74(4):846-50.
2009: Shirodkar Samir P; Kishore T A; Soloway Mark S
The risk and prophylactic management of bladder cancer after various forms of radiotherapy.
Current opinion in urology 2009;19(5):500-3.
2009: Sachedina Nasheer; De Los Santos Rosely; Manoharan Murugesan; Soloway Mark S
Total prostatectomy and lymph node dissection may be done safely without pelvic drainage: an extended experience of over 600 cases.
The Canadian journal of urology 2009;16(4):4721-5.
2009: Shirodkar Samir P; Ciancio Gaetano; Soloway Mark S
Words of wisdom. Re: Intraoperative thrombus embolization during nephrectomy and tumor thrombectomy: critical analysis of the University of California-Los Angeles experience.
European urology 2009;55(6):1485-6.
2009: Soloway Mark S
Editorial comment. With many other neoplasms, bladder cancer is heterogeneous.
Urology 2009;73(6):1311.
2009: Ciancio Gaetano; Soloway Mark; Livingstone Alan S
The increasing use of liver transplantation surgical techniques in the management of renal and nonrenal cancer with or without inferior vena cava tumor thrombus.
World journal of surgery 2009;33(6):1328-9; author reply 1330-1.
2009: Eggener Scott E; Mueller Alex; Berglund Ryan K; Ayyathurai Raj; Soloway Cindy; Soloway Mark S; Abouassaly Robert; Klein Eric A; Jones Steven J; Zappavigna Chris; Goldenberg Larry; Scardino Peter T; Eastham James A; Guillonneau Bertrand
A multi-institutional evaluation of active surveillance for low risk prostate cancer.
The Journal of urology 2009;181(4):1635-41; discussion 1641.
2009: Soloway Mark S
Legends of urology.
The Canadian journal of urology 2009;16(1):4447-9.
2009: Cerwinka Wolfgang H; Manoharan Murugesan; Soloway Mark S; Ciancio Gaetano
The role of liver transplantation techniques in the surgical management of advanced renal urothelial carcinoma with or without inferior vena cava thrombus.
International braz j urol : official journal of the Brazilian Society of Urology 2009;35(1):19-23.
2009: Soloway Mark
Incomplete prostatectomy for cancer.
Current urology reports 2009;10(1):1-3.
2008: Manoharan M; Ayyathurai R; de Los Santos R; Nieder A M; Soloway M S
Presentation and outcome following radical cystectomy in Hispanics with bladder cancer.
International braz j urol : official journal of the Brazilian Society of Urology 2008;34(6):691-8; discussion 698.
2008: Soloway Mark
A 43-year-old African American man with low-risk prostate cancer.
Current urology reports 2008;9(6):437; discussion 437-40.
2008: Nieder Alan M; Porter Michael P; Soloway Mark S
Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.
The Journal of urology 2008;180(5):2005-9; discussion 2009-10.
2008: Delis Spiros G; Bakogiannis Andreas; Ciancio Gaetano; Soloway Mark
Surgical management of large adrenal tumours: the University of Miami experience using liver transplantation techniques.
BJU international 2008;102(10):1394-9.
2008: Lokeshwar Vinata B; Gomez Pablo; Kramer Mario; Knapp Judith; McCornack Melissa A; Lopez Luis E; Fregien Nevis; Dhir Neetika; Scherer Steve; Klumpp David J; Manoharan Murugesan; Soloway Mark S; Lokeshwar Bal L
Epigenetic regulation of HYAL-1 hyaluronidase expression. identification of HYAL-1 promoter.
The Journal of biological chemistry 2008;283(43):29215-27.
2008: Nieder Alan M; Soloway Mark S
It's not a radical prostatectomy, it's a total prostatectomy.
European urology 2008;54(4):715-6.
2008: Soloway Mark
A 49-year-old Hispanic male with intraepithelial neoplasia and focal atypia.
Current urology reports 2008;9(5):342-5.
2008: Soloway Mark S
Editorial comment on: robotic-assisted laparoscopic radical cystectomy with extracorporeal urinary diversion: initial experience.
European urology 2008;54(3):580.
2008: Soloway Mark S
Editorial comment on: EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder.
European urology 2008;54(2):313-4.
2008: Soloway Mark
Squamous cell carcinoma with lamina propria invasion in an 84-year-old physician who prefers to avoid total cystectomy.
Current urology reports 2008;9(4):259; discussion 259-61.
2008: Caruso Daniel J; Carmack Adrienne J K; Lokeshwar Vinata B; Duncan Robert C; Soloway Mark S; Lokeshwar Bal L
Osteopontin and interleukin-8 expression is independently associated with prostate cancer recurrence.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(13):4111-8.
2008: Rajinikanth Ayyathurai; Manoharan Murugesan; Soloway Cynthia T; Civantos Francisco J; Soloway Mark S
Trends in Gleason score: concordance between biopsy and prostatectomy over 15 years.
Urology 2008;72(1):177-82.
2008: Soloway Mark
Possible malignancy after cytology analysis in a 45-year-old man.
Current urology reports 2008;9(3):182-4.
2008: Ayyathurai Rajinikanth; Manoharan Murugesan; Nieder Alan M; Kava Bruce; Soloway Mark S
Factors affecting erectile function after radical retropubic prostatectomy: results from 1620 consecutive patients.
BJU international 2008;101(7):833-6.
2008: Soloway Mark
Recurrence of prostate cancer after radical prostatectomy in a 57-year-old man.
Current urology reports 2008;9(2):91-3.
2008: Soloway Mark
A small mass in a single testis after orchiectomy for testis cancer.
Current urology reports 2008;9(1):3-4.
2008: Bostrom Peter J; Soloway Mark S; Manoharan Murugesan; Ayyathurai Rajinikanth; Samavedi Srinivas
Bladder cancer after radiotherapy for prostate cancer: detailed analysis of pathological features and outcome after radical cystectomy.
The Journal of urology 2008;179(1):91-5; discussion 95.
2008: Soloway Mark S; Soloway Cynthia T; Williams Steve; Ayyathurai Rajinikanth; Kava Bruce; Manoharan Murugesan
Active surveillance; a reasonable management alternative for patients with prostate cancer: the Miami experience.
BJU international 2008;101(2):165-9.
2008: Soloway Mark S
Thromboembolism prophylaxis and total prostatectomy: is pharmacologic therapy required?
European urology 2008;53(1):21-3.
2008: Manoharan M; Ayyathurai R; Nieder A M; Soloway M S
Modified Pfannenstiel approach for radical retropubic prostatectomy: a 3-year experience.
Prostate cancer and prostatic diseases 2008;11(1):74-8.
2007: Soloway Mark S
It is time to abandon the "superficial" in bladder cancer.
European urology 2007;52(6):1564-5.
2007: Ayyathurai Rajinikanth; Gomez Pablo; Luongo Tony; Soloway Mark S; Manoharan Murugesan
Prostatic involvement by urothelial carcinoma of the bladder: clinicopathological features and outcome after radical cystectomy.
BJU international 2007;100(5):1021-5.
2007: Cooke T; Ciancio G; Burke G W; Soloway M S; Manoharan M
Orthotopic ileal neobladder reconstruction after renal transplant.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2007;7(11):2630-3.
2007: Bostrom Peter J; Soloway Mark S
Secondary cancer after radiotherapy for prostate cancer: should we be more aware of the risk?
European urology 2007;52(4):973-82.
2007: Soloway Mark
A 79-year-old man with urothelial carcinoma of the bladder and upper urinary tract.
Current urology reports 2007;8(5):349-50.
2007: Soloway Mark
Urinary tract infection and a small stone.
Current urology reports 2007;8(4):255-8.
2007: Soloway Mark S
Re: The use of enoxaparin to prevent venous thromboembolism in patients undergoing radical retropubic prostatectomy: feasibility and utility.
International braz j urol : official journal of the Brazilian Society of Urology 2007;33(4):565-6.
2007: Soloway Mark S; Lee Cheryl T; Steinberg Gary D; Ghandi Abdullah Al; Jewett Michael A S
Difficult decisions in urologic oncology: management of high-grade T1 transitional cell carcinoma of the bladder.
Urologic oncology 2007;25(4):338-40.
2007: Bostrom Peter J; Soloway Mark S
Upper urinary tract cancer--challenges for the urologist.
The Journal of urology 2007;178(1):12-3.
2007: Nieder Alan M; Soloway Mark S; Jewett Michael A S
Re: can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy? H. W. Herr, S. M. Donat and G. Dalbagni J Urol 2007; 177: 75-79.
The Journal of urology 2007;178(1):352.
2007: Ramachandran Kavitha; Soloway Mark S; Singal Rakesh; Manoharan Murugesan
The emerging role of epigenetics in urological cancers.
The Canadian journal of urology 2007;14(3):3535-41.
2007: Ayyathurai Rajinikanth; Civantos Francisco; Soloway Mark S; Manoharan Murugesan
Basal cell carcinoma of the prostate: current concepts.
BJU international 2007;99(6):1345-9.
2007: Nieder Alan M; Soloway Mark S; Herr Harry W
Should we abandon the FISH test?
European urology 2007;51(6):1469-71.
2007: Nieder Alan M; Manoharan Murugesan; Yang Yulong; Soloway Mark S
Intraoperative cell salvage during radical cystectomy does not affect long-term survival.
Urology 2007;69(5):881-4.
2007: Soloway Mark
Young man with locally advanced prostate cancer.
Current urology reports 2007;8(3):181-2.
2007: Golshani Roozbeh; Hautmann Stefan H; Estrella Veronica; Cohen Brian L; Kyle Christopher C; Manoharan Murugesan; Jorda Merce; Soloway Mark S; Lokeshwar Vinata B
HAS1 expression in bladder cancer and its relation to urinary HA test.
International journal of cancer. Journal international du cancer 2007;120(8):1712-20.
2007: Ciancio Gaetano; Livingstone Alan S; Soloway Mark
Surgical management of renal cell carcinoma with tumor thrombus in the renal and inferior vena cava: the University of Miami experience in using liver transplantation techniques.
European urology 2007;51(4):988-94; discussion 994-5.
2007: Reyes Martha A; Nieder Alan M; Kava Bruce R; Soloway Mark S; Manoharan Murugesan
Does body mass index affect outcome after reconstruction of orthotopic neobladder?
Urology 2007;69(3):475-8.
2007: Soloway Mark
High-grade T1 bladder cancer at the ureterovesical junction.
Current urology reports 2007;8(2):104-7.
2007: Nieder Alan M; Soloway Mark S
We are not yet ready to abandon cystoscopy.
Nature clinical practice. Urology 2007;4(3):130-1.
2007: Araki Motoo; Nieder Alan M; Manoharan Murugesan; Yang Yulong; Soloway Mark S
Lack of progress in early diagnosis of bladder cancer.
Urology 2007;69(2):270-4.
2007: Manoharan Murugesan; Ramachandran Kavitha; Soloway Mark S; Singal Rakesh
Epigenetic targets in the diagnosis and treatment of prostate cancer.
International braz j urol : official journal of the Brazilian Society of Urology 2007;33(1):11-8.
2007: Sternberg Cora N; Donat S Machele; Bellmunt Joaquim; Millikan Randall E; Stadler Walter; De Mulder Pieter; Sherif Amir; von der Maase Hans; Tsukamoto Taiji; Soloway Mark S
Chemotherapy for bladder cancer: treatment guidelines for neoadjuvant chemotherapy, bladder preservation, adjuvant chemotherapy, and metastatic cancer.
Urology 2007;69(1 Suppl):62-79.
2007: Malkowicz S Bruce; van Poppel Hendrik; Mickisch Gerald; Pansadoro Vito; Thüroff Joachim; Soloway Mark S; Chang Sam; Benson Mitchell; Fukui Iwao
Muscle-invasive urothelial carcinoma of the bladder.
Urology 2007;69(1 Suppl):3-16.
2007: Manoharan M; Ayyathurai R; Nieder A M; Soloway M S
Hemospermia following transrectal ultrasound-guided prostate biopsy: a prospective study.
Prostate cancer and prostatic diseases 2007;10(3):283-7.
2006: Lokeshwar Vinata B; Estrella Veronica; Lopez Luis; Kramer Mario; Gomez Pablo; Soloway Mark S; Lokeshwar Bal L
HYAL1-v1, an alternatively spliced variant of HYAL1 hyaluronidase: a negative regulator of bladder cancer.
Cancer research 2006;66(23):11219-27.
2006: Manoharan M; Gomez Pablo; Reyes Martha A; Soloway Mark S
Metastatic adenoid cystic carcinoma to the kidney in a young woman.
Urology 2006;68(6):1343.e11-2.
2006: Araki Motoo; Manoharan Murugesan; Vyas Sachin; Nieder Alan M; Soloway Mark S
A pelvic drain can often be avoided after radical retropubic prostatectomy--an update in 552 cases.
European urology 2006;50(6):1241-7; discussion 1246-7.
2006: Ciancio Gaetano; Soloway Mark
Endoluminal occlusion of the inferior vena cava in renal cell carcinoma with retro- or suprahepatic caval thrombus.
BJU international 2006;98(4):915.
2006: Manoharan Murugesan; Reyes Martha A; Singal Rakesh; Kava Bruce R; Nieder Alan M; Soloway Mark S
Orthotopic ileal neobladder reconstruction for bladder cancer: is adjuvant chemotherapy safe?
International braz j urol : official journal of the Brazilian Society of Urology 2006;32(5):529-35.
2006: Cohen Brian L; Gomez Pablo; Omori Yohei; Duncan Robert C; Civantos Francisco; Soloway Mark S; Lokeshwar Vinata B; Lokeshwar Bal L
Cyclooxygenase-2 (COX-2) expression is an independent predictor of prostate cancer recurrence.
International journal of cancer. Journal international du cancer 2006;119(5):1082-7.
2006: Ciancio Gaetano; Cerwinka Wolfgang H; Soloway Mark S
En bloc mobilization of the inferior vena cava and large hypervascular right renal tumors with or without inferior vena cava thrombus: Posterior ligation of the renal artery.
International journal of urology : official journal of the Japanese Urological Association 2006;13(8):1144-6.
2006: Manoharan Murugesan; Vyas Sachin; Araki Motoo; Nieder Alan M; Soloway Mark S
Concurrent radical retropubic prostatectomy and Lichtenstein inguinal hernia repair through a single modified Pfannenstiel incision: a 3-year experience.
BJU international 2006;98(2):341-4.
2006: Koya Madhusudan P; Simon Michael A; Soloway Mark S
Complications of intravesical therapy for urothelial cancer of the bladder.
The Journal of urology 2006;175(6):2004-10.
2006: Soloway Mark S
Frozen sections for positive margins?
European urology 2006;49(6):950-1.
2006: Nieder Alan M; Simon Michael A; Kim Sandy S; Manoharan Murugesan; Soloway Mark S
Radical cystectomy after bacillus Calmette-Guérin for high-risk Ta, T1, and carcinoma in situ: defining the risk of initial bladder preservation.
Urology 2006;67(4):737-41.
2006: Grossman H Barton; Blute Michael L; Dinney Colin P N; Jones J Stephen; Liou Louis S; Reuter Victor E; Soloway Mark S
The use of urine-based biomarkers in bladder cancer.
Urology 2006;67(3 Suppl 1):62-4.
2006: Carmack Adrienne J K; Soloway Mark S
The diagnosis and staging of bladder cancer: from RBCs to TURs.
Urology 2006;67(3 Suppl 1):3-8; discussion 8-10.
2006: Nieder Alan M; Soloway Mark S
Eliminate the term "superficial" bladder cancer.
The Journal of urology 2006;175(2):417-8.
2006: Grossman H Barton; Soloway Mark; Messing Edward; Katz Giora; Stein Barry; Kassabian Vahan; Shen Yu
Surveillance for recurrent bladder cancer using a point-of-care proteomic assay.
JAMA : the journal of the American Medical Association 2006;295(3):299-305.
2006: Soloway Mark S
Expectant treatment of small, recurrent, low-grade, noninvasive tumors of the urinary bladder.
Urologic oncology 2006;24(1):58-61.
2006: Simon Michael A; Kim Sandy; Soloway Mark S
Prostate specific antigen recurrence rates are low after radical retropubic prostatectomy and positive margins.
The Journal of urology 2006;175(1):140-4; discussion 144-5.
2006: Ciancio Gaetano; Soloway Mark
Tumour nephrectomy with vena cava thrombus.
BJU international 2006;97(1):198-9.
2005: Cerwinka Wolfgang H; Ciancio Gaetano; Salerno Thomas A; Soloway Mark S
Renal cell cancer with invasive atrial tumor thrombus excised off-pump.
Urology 2005;66(6):1319.
2005: Manoharan Murugesan; Reyes Martha A; Kava Bruce R; Singal Rakesh; Kim Sandy S; Soloway Mark S
Is adjuvant chemotherapy for bladder cancer safer in patients with an ileal conduit than a neobladder?
BJU international 2005;96(9):1286-9.
2005: Nieder Alan M; Meinbach David S; Kim Sandy S; Soloway Mark S
Transurethral bladder tumor resection: intraoperative and postoperative complications in a residency setting.
The Journal of urology 2005;174(6):2307-9.
2005: Soloway Mark; Roach Mack
Prostate cancer progression after therapy of primary curative intent: a review of data from prostate-specific antigen era.
Cancer 2005;104(11):2310-22.
2005: Koya Madhusudan P; Manoharan Murugesan; Kim Sandy S; Soloway Mark S
Venous thromboembolism in radical prostatectomy: is heparinoid prophylaxis warranted?
BJU international 2005;96(7):1019-21.
2005: Ciancio Gaetano; Soloway Mark
Re: renal cell carcinoma with renal vein and inferior vena caval involvement: clinicopathological features, surgical techniques and outcomes.
The Journal of urology 2005;174(5):2067; author reply 2067.
2005: Ciancio Gaetano; Soloway Mark
Resection of the abdominal inferior vena cava for complicated renal cell carcinoma with tumour thrombus.
BJU international 2005;96(6):815-8.
2005: Soloway Mark S
Bladder carcinoma: where are the patient advocates?
Cancer 2005;104(8):1559-62.
2005: Ciancio Gaetano; Soloway Mark S
Renal cell carcinoma with tumor thrombus extending above diaphragm: avoiding cardiopulmonary bypass.
Urology 2005;66(2):266-70.
2005: Koya Madhusudan P; Soloway Mark S
Re: Examining the location and the cause of death within 30 days of radical prostatectomy.
BJU international 2005;95(9):1369.
2005: Soloway Mark S
Editorial comment.
International braz j urol : official journal of the Brazilian Society of Urology 2005;31(3):212; author reply 212-3.
2005: Nieder Alan M; Sved Paul D; Stein John P; Skinner Donald G; Soloway Mark S
Cystoprostatectomy and orthotopic ileal neobladder reconstruction for management of bacille Calmette Guérin-induced bladder contractures.
Urology 2005;65(5):909-12.
2005: Manoharan Murugesan; Soloway Mark S
Optimal management of the T1G3 bladder cancer.
The Urologic clinics of North America 2005;32(2):133-45.
2005: Nieder Alan M; Carmack Adrienne J K; Sved Paul D; Kim Sandy S; Manoharan Murugesan; Soloway Mark S
Intraoperative cell salvage during radical prostatectomy is not associated with greater biochemical recurrence rate.
Urology 2005;65(4):730-4.
2005: Soloway Cynthia T; Soloway Mark S; Kim Sandy S; Kava Bruce R
Sexual, psychological and dyadic qualities of the prostate cancer 'couple'.
BJU international 2005;95(6):780-5.
2005: Sved Paul D; Nieder Alan M; Manoharan Murugesan; Gomez Pablo; Meinbach David S; Kim Sandy S; Soloway Mark S
Evaluation of analgesic requirements and postoperative recovery after radical retropubic prostatectomy using long-acting spinal anesthesia.
Urology 2005;65(3):509-12.
2005: Grossman H Barton; Messing Edward; Soloway Mark; Tomera Kevin; Katz Giora; Berger Yitzhak; Shen Yu
Detection of bladder cancer using a point-of-care proteomic assay.
JAMA : the journal of the American Medical Association 2005;293(7):810-6.
2005: Nieder Alan M; Manoharan Murugesan; Kim Sandy S; Soloway Mark S
Neither alpha-blocker therapy nor cystography is required before early catheter removal after radical prostatectomy.
BJU international 2005;95(3):323-5.
2005: Soloway Mark S
Re: Schrier BPh, Hollander MP, van Rhijn BWG, Kiemeney LALM, Witjes JA. Prognosis of muscle-invasive bladder cancer: difference between primary and progressive tumours and implications for therapy. Eur Urol 2004;45:292-6.
European urology 2005;47(2):264; author reply 264.
2004: Nieder Alan M; Sved Paul D; Gomez Pablo; Kim Sandy S; Manoharan Murugesan; Soloway Mark S
Urethral recurrence after cystoprostatectomy: implications for urinary diversion and monitoring.
Urology 2004;64(5):950-4.
2004: Sved Paul D; Gomez Pablo; Nieder Alan M; Manoharan Murugesan; Kim Sandy S; Soloway Mark S
Upper tract tumour after radical cystectomy for transitional cell carcinoma of the bladder: incidence and risk factors.
BJU international 2004;94(6):785-9.
2004: Ekici Sinan; Cerwinka Wolfgang H; Duncan Robert; Gomez Pablo; Civantos Francisco; Soloway Mark S; Lokeshwar Vinata B
Comparison of the prognostic potential of hyaluronic acid, hyaluronidase (HYAL-1), CD44v6 and microvessel density for prostate cancer.
International journal of cancer. Journal international du cancer 2004;112(1):121-9.
2004: Nieder Alan M; Simon Michael A; Kim Sandy S; Manoharan Murugesan; Soloway Mark S
Intraoperative cell salvage during radical prostatectomy: a safe technique for Jehovah's Witnesses.
International braz j urol : official journal of the Brazilian Society of Urology 2004;30(5):377-9.
2004: Manoharan M; Gomez Pablo; Sved Paul; Soloway Mark S
Modified Pfannenstiel approach for radical retropubic prostatectomy.
Urology 2004;64(2):369-71.
2004: Gomez Pablo; Manoharan Marugesan; Kim Sandy S; Soloway Mark S
Radionuclide bone scintigraphy in patients with biochemical recurrence after radical prostatectomy: when is it indicated?
BJU international 2004;94(3):299-302.
2004: Sved Paul; Gomez Pablo; Manoharan Marugesan; Civantos Francisco; Soloway Mark S
Small cell carcinoma of the bladder.
BJU international 2004;94(1):12-7.
2004: Sved Paul D; Gomez Pablo; Manoharan M; Kim Sandy S; Soloway Mark S
Limitations of biopsy Gleason grade: implications for counseling patients with biopsy Gleason score 6 prostate cancer.
The Journal of urology 2004;172(1):98-102.
2004: Delis Spiros; Dervenis Christos; Lytras Dimitrios; Avgerinos Costas; Soloway Mark; Ciancio Gaetano
Liver transplantation techniques with preservation of the natural venovenous bypass: effect on surgical resection of renal cell carcinoma invading the inferior vena cava.
World journal of surgery 2004;28(6):614-9.
2004: Manoharan M; Gomez P; Soloway M S
Concurrent radical retropubic prostatectomy and inguinal hernia repair through a modified Pfannenstiel incision.
BJU international 2004;93(9):1203-6.
2004: Gomez Pablo; Manoharan Muruqesan; Sved Paul; Kim Sandy S; Soloway Mark S
Radical retropubic prostatectomy in Hispanic patients.
Cancer 2004;100(8):1628-32.
2003: Akaza Hideyuki; Hirao Yoshihiko; Labrie Fernand; Soloway Mark S
[Future prospects for primary hormone therapy in localized and locally advanced prostate cancer]
Hinyokika kiyo. Acta urologica Japonica 2003;49(12):771-7.
2003: Soloway Mark S
Do unto others--why I would want anesthesia for my prostate biopsy.
Urology 2003;62(6):973-5.
2003: Soloway Mark S
Editorial: Bladder cancer. How can we make a difference?
The Journal of urology 2003;170(5):1781-2.
2003: Manoharan M; Bird V G; Kim S S; Civantos F; Soloway M S
Outcome after radical prostatectomy with a pretreatment prostate biopsy Gleason score of >/=8.
BJU international 2003;92(6):539-44.
2003: Manoharan M; Civantos Francisco; Kim Sandy S; Gomez Pablo; Soloway Mark S
Visual estimate of percent of carcinoma predicts recurrence after radical prostatectomy.
The Journal of urology 2003;170(4 Pt 1):1194-8.
2003: Moul J W; Anderson J; Penson D F; Klotz L H; Soloway M S; Schulman C C
Early prostate cancer: prevention, treatment modalities, and quality of life issues.
European urology 2003;44(3):283-93.
2003: Ciancio G; Vaidya A; Soloway M
Early ligation of the renal artery using the posterior approach: a basic surgical concept reinforced during resection of large hypervascular renal cell carcinoma with or without inferior vena cava thrombus.
BJU international 2003;92(4):488-9.
2003: Simon Michael A; Lokeshwar Vinata B; Soloway Mark S
Current bladder cancer tests: unnecessary or beneficial?
Critical reviews in oncology/hematology 2003;47(2):91-107.
2003: Soloway Mark S; Bruck Darren S; Kim Sandy S
Expectant management of small, recurrent, noninvasive papillary bladder tumors.
The Journal of urology 2003;170(2 Pt 1):438-41.
2003: Savoie Marc; Soloway Mark S; Kim Sandy S; Manoharan M
A pelvic drain may be avoided after radical retropubic prostatectomy.
The Journal of urology 2003;170(1):112-4.
2003: Dandekar Devendra S; Lokeshwar Vinata B; Cevallos-Arellano Edwin; Soloway Mark S; Lokeshwar Balakrishna L
An orally active Amazonian plant extract (BIRM) inhibits prostate cancer growth and metastasis.
Cancer chemotherapy and pharmacology 2003;52(1):59-66.
2003: Soloway M S
Where are the 'poster boys' for bladder cancer?
BJU international 2003;91(9):769-70.
2003: Posey J Timothy; Soloway Mark S; Ekici Sinan; Sofer Mario; Civantos Francisco; Duncan Robert C; Lokeshwar Vinata B
Evaluation of the prognostic potential of hyaluronic acid and hyaluronidase (HYAL1) for prostate cancer.
Cancer research 2003;63(10):2638-44.
2003: Soloway M S
Does pericapsular lignocaine reduce pain during transrectal ultrasonography-guided biopsy of the prostate?
BJU international 2003;91(6):583-4; discussion 584.
2003: Davis M; Sofer M; Gomez-Marin O; Bruck D; Soloway M S
The use of cell salvage during radical retropubic prostatectomy: does it influence cancer recurrence?
BJU international 2003;91(6):474-6.
2003: Savoie Marc; Kim Sandy S; Soloway Mark S
A prospective study measuring penile length in men treated with radical prostatectomy for prostate cancer.
The Journal of urology 2003;169(4):1462-4.
2003: Vaidya Anil; Ciancio Gaetano; Soloway Mark
Surgical techniques for treating a renal neoplasm invading the inferior vena cava.
The Journal of urology 2003;169(2):435-44.
2003: Neulander Endre Z; Soloway Mark S
Failure after radical prostatectomy.
Urology 2003;61(1):30-6.
2003: Sofer Mario; Savoie Marc; Kim Sandy S; Civantos Francisco; Soloway Mark S
Biochemical and pathological predictors of the recurrence of prostatic adenocarcinoma with seminal vesicle invasion.
The Journal of urology 2003;169(1):153-6.
2002: Soloway Mark S
Timing of androgen deprivation for prostate cancer: benefits versus side effects--a patient-physician dialogue.
Urology 2002;60(5):735-7.
2002: Sarosdy Michael F; Schellhammer Paul; Bokinsky Gary; Kahn Paul; Chao Roberto; Yore Lawrence; Zadra Joseph; Burzon Daniel; Osher Gerald; Bridge Julia A; Anderson Steven; Johansson Sonny L; Lieber Michael; Soloway Mark; Flom Kerry
Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer.
The Journal of urology 2002;168(5):1950-4.
2002: Ciancio Gaetano; Vaidya Anil; Savoie Mark; Soloway Mark
Management of renal cell carcinoma with level III thrombus in the inferior vena cava.
The Journal of urology 2002;168(4 Pt 1):1374-7.
2002: Lokeshwar Vinata B; Schroeder Grethchen L; Carey Robert I; Soloway Mark S; Iida Naoko
Regulation of hyaluronidase activity by alternative mRNA splicing.
The Journal of biological chemistry 2002;277(37):33654-63.
2002: Lokeshwar Vinata B; Schroeder Grethchen L; Selzer Marie G; Hautmann Stefan H; Posey J Timothy; Duncan Robert C; Watson Roger; Rose Lyndon; Markowitz Steven; Soloway Mark S
Bladder tumor markers for monitoring recurrence and screening comparison of hyaluronic acid-hyaluronidase and BTA-Stat tests.
Cancer 2002;95(1):61-72.
2002: Sofer Mario; Hamilton-Nelson Kara L; Civantos Francisco; Soloway Mark S
Positive surgical margins after radical retropubic prostatectomy: the influence of site and number on progression.
The Journal of urology 2002;167(6):2453-6.
2002: Ciancio Gaetano; Soloway Mark
The use of natural veno-venous bypass during surgical treatment of renal cell carcinoma with inferior vena cava thrombus.
The American surgeon 2002;68(5):488-90.
2002: Soloway Mark S
Progression and survival in patients with T1G3 bladder tumors.
Urology 2002;59(4):631; author reply 631.
2002: Sofer Mario; Hamilton-Nelson Kara L; Schlesselman James J; Soloway Mark S
Risk of positive margins and biochemical recurrence in relation to nerve-sparing radical prostatectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(7):1853-8.
2002: Soloway Mark S; Sofer Mario; Vaidya Anil
Contemporary management of stage T1 transitional cell carcinoma of the bladder.
The Journal of urology 2002;167(4):1573-83.
2002: Lokeshwar Vinata B; Soloway Mark S
Re: Urine based markers of urological malignancy.
The Journal of urology 2002;167(3):1406-7.
2002: Davis Michael; Sofer Mario; Kim Sandy S; Soloway Mark S
The procedure of transrectal ultrasound guided biopsy of the prostate: a survey of patient preparation and biopsy technique.
The Journal of urology 2002;167(2 Pt 1):566-70.
2002: Soloway Mark S; Pareek Kapil; Sharifi Rooholiah; Wajsman Zev; McLeod David; Wood David P; Puras-Baez Antonio;
Neoadjuvant androgen ablation before radical prostatectomy in cT2bNxMo prostate cancer: 5-year results.
The Journal of urology 2002;167(1):112-6.
2001: Soloway M S
Re: urinary continence and pathological outcome after bladder neck preservation during radical retropubic prostatectomy: a randomized prospective trial.
The Journal of urology 2001;166(5):1838-9.
2001: Ciancio G; Soloway M
Renal cell carcinoma invading the hepatic veins.
Cancer 2001;92(7):1836-42.
2001: Alavi A S; Soloway M S; Vaidya A; Lynne C M; Gheiler E L
Local anesthesia for ultrasound guided prostate biopsy: a prospective randomized trial comparing 2 methods.
The Journal of urology 2001;166(4):1343-5.
2001: Vaidya A; Soloway M S
Periprostatic local anesthesia before ultrasound-guided prostate biopsy: an update of the miami experience.
European urology 2001;40(2):135-8.
2001: Soloway M S
Bladder tumor markers, intravesical therapy and systemic chemotherapy.
The Journal of urology 2001;166(2):488-9.
2001: Hautmann S H; Lokeshwar V B; Schroeder G L; Civantos F; Duncan R C; Gnann R; Friedrich M G; Soloway M S
Elevated tissue expression of hyaluronic acid and hyaluronidase validates the HA-HAase urine test for bladder cancer.
The Journal of urology 2001;165(6 Pt 1):2068-74.
2001: Vaidya A; Hawke C; Tiguert R; Civantos F; Soloway M
Intraoperative T staging in radical retropubic prostatectomy: is it reliable?
Urology 2001;57(5):949-54.
2001: Lokeshwar V B; Soloway M S
Current bladder tumor tests: does their projected utility fulfill clinical necessity?
The Journal of urology 2001;165(4):1067-77.
2001: Hautmann S H; Schroeder G L; Civantos F; Duncan R C; Gnann R; Friedrich M G; Hellstern A; Huland H; Soloway M S; Lokeshwar V B
[Hyaluronic acid and hyaluronidase. 2 new bladder carcinoma markers]
Der Urologe. Ausg. A 2001;40(2):121-6.
2001: Tiguert R; Ciancio G; Ravery V; Soloway M S
[Contribution of surgical techniques used in liver transplantation in the treatment of retroperitoneal tumors]
Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie 2001;11(1):145-7; discussion 147-8.
2001: Vaidya A; Soloway M S; Hawke C; Tiguert R; Civantos F
De novo muscle invasive bladder cancer: is there a change in trend?
The Journal of urology 2001;165(1):47-50; discussion 50.
2000: Vaidya A; Soloway M S
Salvage radical prostatectomy for radiorecurrent prostate cancer: morbidity revisited.
The Journal of urology 2000;164(6):1998-2001.
2000: Fowler J E; Gottesman J E; Reid C F; Andriole G L; Soloway M S
Safety and efficacy of an implantable leuprolide delivery system in patients with advanced prostate cancer.
The Journal of urology 2000;164(3 Pt 1):730-4.
2000: Ciancio G; Hawke C; Soloway M
The use of liver transplant techniques to aid in the surgical management of urological tumors.
The Journal of urology 2000;164(3 Pt 1):665-72.
2000: Gomella L G; Albertsen P C; Benson M C; Forman J D; Soloway M S
The use of video-based patient education for shared decision-making in the treatment of prostate cancer.
Seminars in urologic oncology 2000;18(3):182-7.
2000: Neulander E Z; Hawke C K; Soloway M S
Incidental appendectomy during radical cystectomy: an interdepartmental survey and review of the literature.
Urology 2000;56(2):241-4.
2000: Posey J T; Neulander E Z; Soloway M S; Civantos F
Signet ring cell carcinoma of a pulled-through sigmoid colon mimicking a primary invasive bladder tumor: case report and review of the literature.
Urology 2000;55(6):949.
2000: Neulander E Z; Duncan R C; Tiguert R; Posey J T; Soloway M S
Deferred treatment of localized prostate cancer in the elderly: the impact of the age and stage at the time of diagnosis on the treatment decision.
BJU international 2000;85(6):699-704.
2000: Rubinowicz D M; Soloway M S; Lief M; Civantos F
Hemospermia and expressed tumor in the urethra: an unusual presentation of ductal carcinoma of the prostate.
The Journal of urology 2000;163(3):915.
2000: Soloway M S; Neulander E
Bladder-neck preservation during radical retropubic prostatectomy.
Seminars in urologic oncology 2000;18(1):51-6.
2000: Lokeshwar V B; Obek C; Pham H T; Wei D; Young M J; Duncan R C; Soloway M S; Block N L
Urinary hyaluronic acid and hyaluronidase: markers for bladder cancer detection and evaluation of grade.
The Journal of urology 2000;163(1):348-56.
2000: Soloway M S; Obek C
Periprostatic local anesthesia before ultrasound guided prostate biopsy.
The Journal of urology 2000;163(1):172-3.
1999: Smith J A; Soloway M S; Young M J
Complications of advanced prostate cancer.
Urology 1999;54(6A Suppl):8-14.
1999: Obek C; Sadek S; Lai S; Civantos F; Rubinowicz D; Soloway M S
Positive surgical margins with radical retropubic prostatectomy: anatomic site-specific pathologic analysis and impact on prognosis.
Urology 1999;54(4):682-8.
1999: Obek C; Lai S; Sadek S; Civantos F; Soloway M S
Age as a prognostic factor for disease recurrence after radical prostatectomy.
Urology 1999;54(3):533-8.
1999: Obek C; Neulander E; Sadek S; Soloway M S
Is there a role for digital rectal examination in the followup of patients after radical prostatectomy?
The Journal of urology 1999;162(3 Pt 1):762-4.
1999: McLeod D G; Schellhammer P F; Vogelzang N J; Soloway M S; Sharifi R; Block N L; Venner P M; Patterson A L; Sarosdy M F; Kelley R P; Kolvenbag G J
Exploratory analysis on the effect of race on clinical outcome in patients with advanced prostate cancer receiving bicalutamide or flutamide, each in combination with LHRH analogues. The Casodex Combination Study Group.
The Prostate 1999;40(4):218-24.
1999: Sarosdy M F; Schellhammer P F; Soloway M S; Vogelzang N J; Crawford E D; Presti J; Chodak G W; Mitchell P; Porter L
Endocrine effects, efficacy and tolerability of a 10.8-mg depot formulation of goserelin acetate administered every 13 weeks to patients with advanced prostate cancer.
BJU international 1999;83(7):801-6.
1999: Obek C; Louis P; Civantos F; Soloway M S
Comparison of digital rectal examination and biopsy results with the radical prostatectomy specimen.
The Journal of urology 1999;161(2):494-8; discussion 498-9.
1999: Soloway M S
Do we have a prostate specific antigen for bladder cancer?
The Journal of urology 1999;161(2):447-8.
1999: Sadek S; Soloway M S; Hook S; Civantos F
The value of upper tract cytology after transurethral resection of bladder tumor in patients with bladder transitional cell cancer.
The Journal of urology 1999;161(1):77-9; discussion 79-80.
1999: Obek C; Shelfo S W; Korman H J; Soloway M S
Intravesical therapy for transitional cell carcinoma of the bladder: the community practice.
Urology 1999;53(1):82-7.
1998: Young M J; Soloway M S
Office evaluation and management of bladder neoplasms.
The Urologic clinics of North America 1998;25(4):603-11.
1998: Lokeshwar V B; Soloway M S; Block N L
Secretion of bladder tumor-derived hyaluronidase activity by invasive bladder tumor cells.
Cancer letters 1998;131(1):21-7.
1998: Wieder J A; Soloway M S
Incidence, etiology, location, prevention and treatment of positive surgical margins after radical prostatectomy for prostate cancer.
The Journal of urology 1998;160(2):299-315.
1998: Sarosdy M F; Schellhammer P F; Sharifi R; Block N L; Soloway M S; Venner P M; Patterson A L; Vogelzang N J; Chodak G W; Klein E A; Schellenger J J; Kolvenbag G J
Comparison of goserelin and leuprolide in combined androgen blockade therapy.
Urology 1998;52(1):82-8.
1998: Soloway D; Simon M A; Milikowski C; Soloway M S
Epithelioid leiomyoma of the bladder: an unusual cause of voiding symptoms.
Urology 1998;51(6):1037-9.
1998: Wieder J A; Soloway M S
Interstitial pneumonitis associated with neoadjuvant leuprolide and nilutamide for prostate cancer.
The Journal of urology 1998;159(6):2099.
1998: Soloway M S
Combined androgen blockade: an optimal therapy for minimally advanced prostate cancer?
British journal of urology 1998;81(1):87-94; discussion 94-5.
1998: Shelfo S W; Obek C; Soloway M S
Update on bladder neck preservation during radical retropubic prostatectomy: impact on pathologic outcome, anastomotic strictures, and continence.
Urology 1998;51(1):73-8.
1998: Soloway M S
T1 and T2 bladder cancer: selecting optimal therapy.
European urology 1998;33 Suppl 4():16-7.
1998: Tyrrell C J; Denis L; Newling D; Soloway M; Channer K; Cockshott I D
Casodex 10-200 mg daily, used as monotherapy for the treatment of patients with advanced prostate cancer. An overview of the efficacy, tolerability and pharmacokinetics from three phase II dose-ranging studies. Casodex Study Group.
European urology 1998;33(1):39-53.
1997: Sarosdy M F; Hudson M A; Ellis W J; Soloway M S; deVere White R; Sheinfeld J; Jarowenko M V; Schellhammer P F; Schervish E W; Patel J V; Chodak G W; Lamm D L; Johnson R D; Henderson M; Adams G; Blumenstein B A; Thoelke K R; Pfalzgraf R D; Murchison H A; Brunelle S L
Improved detection of recurrent bladder cancer using the Bard BTA stat Test.
Urology 1997;50(3):349-53.
1997: Schellhammer P F; Sharifi R; Block N L; Soloway M S; Venner P M; Patterson A L; Sarosdy M F; Vogelzang N J; Schellenger J J; Kolvenbag G J
Clinical benefits of bicalutamide compared with flutamide in combined androgen blockade for patients with advanced prostatic carcinoma: final report of a double-blind, randomized, multicenter trial. Casodex Combination Study Group.
Urology 1997;50(3):330-6.
1997: Pham H T; Soloway M S
High-risk superficial bladder cancer: intravesical therapy for T1 G3 transitional cell carcinoma of the urinary bladder.
Seminars in urologic oncology 1997;15(3):147-53.
1997: Schellhammer P; Cockett A; Boccon-Gibod L; Gospodarowicz M; Krongrad A; Thompson I M; Scardino P; Soloway M; Adolfsson J
Assessment of endpoints for clinical trials for localized prostate cancer.
Urology 1997;49(4A Suppl):27-38.
1997: McLeod D G; Johnson C F; Klein E; Peabody J O; Coffield S; Soloway M
PSA levels and the rate of positive surgical margins in radical prostatectomy specimens preceded by androgen blockade in clinical B2 (T2bNxMo) prostate cancer. The Lupron Depot Neoadjuvant Study Group.
Urology 1997;49(3A Suppl):70-3.
1997: Brady J D; Korman H J; Civantos F; Soloway M S
Fibroepithelial polyp of the renal pelvis: nephron-sparing surgery after false-positive biopsy for transitional cell carcinoma.
Urology 1997;49(3):460-4.
1997: Lokeshwar V B; Obek C; Soloway M S; Block N L
Tumor-associated hyaluronic acid: a new sensitive and specific urine marker for bladder cancer.
Cancer research 1997;57(4):773-7.
1997: Shelfo S W; Soloway M S
The role of nuclear matrix protein 22 in the detection of persistent or recurrent transitional-cell cancer of the bladder.
World journal of urology 1997;15(2):107-11.
1996: Schellhammer P F; Sharifi R; Block N L; Soloway M S; Venner P M; Patterson A L; Sarosdy M F; Vogelzang N J; Chen Y; Kolvenbag G J
A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate carcinoma. Analysis of time to progression. CASODEX Combination Study Group.
Cancer 1996;78(10):2164-9.
1996: Soloway M S
Bladder cancer.
Urology 1996;48(4):631.
1996: Carpinito G A; Stadler W M; Briggman J V; Chodak G W; Church P A; Lamm D L; Lange P H; Messing E M; Pasciak R M; Reservitz G B; Ross R N; Rukstalis D B; Sarosdy M F; Soloway M S; Thiel R P; Vogelzang N; Hayden C L
Urinary nuclear matrix protein as a marker for transitional cell carcinoma of the urinary tract.
The Journal of urology 1996;156(4):1280-5.
1996: Korman H J; Watson R B; Civantos F; Block N L; Soloway M S
Radical prostatectomy: is complete resection of the seminal vesicles really necessary?
The Journal of urology 1996;156(3):1081-3.
1996: Soloway M S; Briggman V; Carpinito G A; Chodak G W; Church P A; Lamm D L; Lange P; Messing E; Pasciak R M; Reservitz G B; Rukstalis D B; Sarosdy M F; Stadler W M; Thiel R P; Hayden C L
Use of a new tumor marker, urinary NMP22, in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment.
The Journal of urology 1996;156(2 Pt 1):363-7.
1996: Watson R B; Civantos F; Soloway M S
Positive surgical margins with radical prostatectomy: detailed pathological analysis and prognosis.
Urology 1996;48(1):80-90.
1996: Watson R; Soloway M S
Is there a role for induction androgen deprivation prior to radical prostatectomy?
Hematology/oncology clinics of North America 1996;10(3):627-41.
1996: Watson R B; Soloway M S
Neoadjuvant hormonal treatment before radical prostatectomy.
Seminars in urologic oncology 1996;14(2 Suppl 2):48-55; discussion 55-6.
1996: Civantos F; Soloway M S; Pinto J E
Histopathological effects of androgen deprivation in prostatic cancer.
Seminars in urologic oncology 1996;14(2 Suppl 2):22-31.
1996: Abbas F; Kaplan M; Soloway M S
Induction androgen deprivation therapy before radical prostatectomy for prostate cancer--initial results.
British journal of urology 1996;77(3):423-8.
1996: Schellhammer P; Sharifi R; Block N; Soloway M; Venner P; Patterson A L; Sarosdy M; Vogelzang N; Jones J; Kolvenbag G
Maximal androgen blockade for patients with metastatic prostate cancer: outcome of a controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy. Casodex Combination Study Group.
Urology 1996;47(1A Suppl):54-60; discussion 80-4.
1996: Soloway M S; Schellhammer P F; Smith J A; Chodak G W; Kennealey G T
Bicalutamide in the treatment of advanced prostatic carcinoma: a phase II multicenter trial.
Urology 1996;47(1A Suppl):33-7; discussion 48-53.
1996: Abbas F; Hochberg D; Civantos F; Soloway M
Incidental prostatic adenocarcinoma in patients undergoing radical cystoprostatectomy for bladder cancer.
European urology 1996;30(3):322-6.
1996: Davi R C; Braslis K G; Perez J L; Soloway M S
Bilateral epidermoid cysts of the testis.
European urology 1996;29(1):122-4.
1996: Soloway M S; Watson R
The role of induction androgen deprivation prior to radical prostatectomy.
European urology 1996;29 Suppl 2():114-8.
1996: Soloway M S; Schellhammer P; Sharifi R; Venner P; Patterson A L; Sarosdy M; Vogelzang N; Jones J; Kolvenbag G
A controlled trial of Casodex (bicalutamide) vs. flutamide, each in combination with luteinising hormone-releasing hormone analogue therapy in patients with advanced prostate cancer. Casodex Combination Study Group.
European urology 1996;29 Suppl 2():105-9.
1995: Soloway M S; Schellhammer P F; Smith J A; Chodak G W; Vogelzang N J; Kennealey G T
Bicalutamide in the treatment of advanced prostatic carcinoma: a phase II noncomparative multicenter trial evaluating safety, efficacy and long-term endocrine effects of monotherapy.
The Journal of urology 1995;154(6):2110-4.
1995: Abbas F; Civantos F; Benedetto P; Soloway M S
Small cell carcinoma of the bladder and prostate.
Urology 1995;46(5):617-30.
1995: Lim A J; Brandon A H; Fiedler J; Brickman A L; Boyer C I; Raub W A; Soloway M S
Quality of life: radical prostatectomy versus radiation therapy for prostate cancer.
The Journal of urology 1995;154(4):1420-5.
1995: Vogelzang N J; Chodak G W; Soloway M S; Block N L; Schellhammer P F; Smith J A; Caplan R J; Kennealey G T
Goserelin versus orchiectomy in the treatment of advanced prostate cancer: final results of a randomized trial. Zoladex Prostate Study Group.
Urology 1995;46(2):220-6.
1995: Sarosdy M F; deVere White R W; Soloway M S; Sheinfeld J; Hudson M A; Schellhammer P F; Jarowenko M V; Adams G; Blumenstein B A
Results of a multicenter trial using the BTA test to monitor for and diagnose recurrent bladder cancer.
The Journal of urology 1995;154(2 Pt 1):379-83; discussion 383-4.
1995: Soloway M S; Sharifi R; Wajsman Z; McLeod D; Wood D P; Puras-Baez A
Randomized prospective study comparing radical prostatectomy alone versus radical prostatectomy preceded by androgen blockade in clinical stage B2 (T2bNxM0) prostate cancer. The Lupron Depot Neoadjuvant Prostate Cancer Study Group.
The Journal of urology 1995;154(2 Pt 1):424-8.
1995: Soloway M S
Role of induction androgen deprivation before radical prostatectomy.
Seminars in urology 1995;13(2):142-7.
1995: Schellhammer P; Sharifi R; Block N; Soloway M; Venner P; Patterson A L; Sarosdy M; Vogelzang N; Jones J; Kolvenbag G
A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate cancer. Casodex Combination Study Group.
Urology 1995;45(5):745-52.
1995: Civantos F; Marcial M A; Banks E R; Ho C K; Speights V O; Drew P A; Murphy W M; Soloway M S
Pathology of androgen deprivation therapy in prostate carcinoma. A comparative study of 173 patients.
Cancer 1995;75(7):1634-41.
1995: Andriole G; Lieber M; Smith J; Soloway M; Schroeder F; Kadmon D; DeKernion J; Rajfer J; Boake R; Crawford D
Treatment with finasteride following radical prostatectomy for prostate cancer.
Urology 1995;45(3):491-7.
1995: Braslis K G; Davi R C; Nelson E; Civantos F; Soloway M S
Squamous cell carcinoma of the prostate: a transformation from adenocarcinoma after the use of a luteinizing hormone-releasing hormone agonist and flutamide.
Urology 1995;45(2):329-31.
1995: Ciancio G; Antun R A; Norberg D G; Mitrani A A; de Marchena E; Soloway M S
Prostate cancer after heart transplantation.
The Journal of urology 1995;153(1):158-60.
1995: Braslis K G; Santa-Cruz C; Brickman A L; Soloway M S
Quality of life 12 months after radical prostatectomy.
British journal of urology 1995;75(1):48-53.
1995: Braslis K G; Petsch M; Lim A; Civantos F; Soloway M S
Bladder neck preservation following radical prostatectomy: continence and margins.
European urology 1995;28(3):202-8.
1994: Braslis K G; Soloway M S
Management of ureteral and renal pelvic recurrence after cystectomy.
The Urologic clinics of North America 1994;21(4):653-9.
1994: Soloway M S
Intravesical therapy for bladder cancer.
The Journal of urology 1994;152(2 Pt 1):379-81.
1994: Soloway M S; Lopez A E; Patel J; Lu Y
Results of radical cystectomy for transitional cell carcinoma of the bladder and the effect of chemotherapy.
Cancer 1994;73(7):1926-31.
1994: Cohen M B; Soloway M S; Murphy W M
Sampling of radical prostatectomy specimens. How much is adequate?
American journal of clinical pathology 1994;101(3):250-2.
1994: Soloway M S; Hachiya T; Civantos F; Murphy W M; Gomez C C; Ruiz H E
Androgen deprivation prior to radical prostatectomy for T2b and T3 prostate cancer.
Urology 1994;43(2 Suppl):52-6.
1994: Matzkin H; Patel J P; Altwein J E; Soloway M S
Stage T1A carcinoma of prostate.
Urology 1994;43(1):11-21.
1993: Gomez C A; Soloway M S; Civantos F; Hachiya T
Bladder neck preservation and its impact on positive surgical margins during radical prostatectomy.
Urology 1993;42(6):689-93; discussion 693-4.
1993: Matzkin H; Perito P E; Soloway M S
Prognostic factors in metastatic prostate cancer.
Cancer 1993;72(12 Suppl):3788-92.
1993: Matzkin H; Soloway M S; Schellhammer P F; Chodak G; Smith J A; Caplan R; Kennealey G T
Prognostic factors in stage D2 prostate cancer treated with a pure nonsteroidal antiandrogen.
Cancer 1993;72(4):1286-90.
1993: Matzkin H; van der Zwaag R; Chen Y; Patterson L A; Braf Z; Soloway M S
How reliable is a single measurement of urinary flow in the diagnosis of obstruction in benign prostatic hyperplasia?
British journal of urology 1993;72(2):181-6.
1993: Jones G W; Smith R A; Batjer J D; Bostwick D G; Corn B W; Guess H A; Hudson M A; Kabalin J; Soloway M S
Workgroup #3: Monitoring effects of treatment for cancer and for benign prostatic hyperplasia.
Cancer 1993;71(8):2681-3.
1993: Matzkin H; Rangel M C; Soloway M S
Relapse on endocrine treatment in patients with stage D2 prostate cancer. Does second-line hormonal therapy affect survival?
Urology 1993;41(2):144-8.
1993: Soloway M S; Matzkin H
Antiandrogenic agents as monotherapy in advanced prostatic carcinoma.
Cancer 1993;71(3 Suppl):1083-8.
1993: Soloway M S
The evaluation and follow-up of patients with Ta, Tcis, and T1 bladder cancer.
World journal of urology 1993;11(3):153-5.
1993: Matzkin H; Soloway M S
Cigarette smoking: a review of possible associations with benign prostatic hyperplasia and prostate cancer.
The Prostate 1993;22(4):277-90.
1993: Soloway M S; Hachiya T; Ruiz H E; Gomez C C; Civantos F
Significance of androgen deprivation prior to radical prostatectomy, with special reference to prostate-specific antigen.
World journal of urology 1993;11(4):221-6.
1992: Soloway M S
Managing superficial bladder cancer: an overview.
Urology 1992;40(6 Suppl):5-10.
1992: Soloway M S; Droller M J; Flanigan R C; Nseyo U O
Superficial bladder disease: case studies and therapeutic advances.
Urology 1992;40(6 Suppl):11-22.
1992: Matzkin H; Eber P; Todd B; van der Zwaag R; Soloway M S
Prognostic significance of changes in prostate-specific markers after endocrine treatment of stage D2 prostatic cancer.
Cancer 1992;70(9):2302-9.
1992: Lepor H; Auerbach S; Puras-Baez A; Narayan P; Soloway M; Lowe F; Moon T; Leifer G; Madsen P
A randomized, placebo-controlled multicenter study of the efficacy and safety of terazosin in the treatment of benign prostatic hyperplasia.
The Journal of urology 1992;148(5):1467-74.
1992: Cassileth B R; Soloway M S; Vogelzang N J; Chou J M; Schellhammer P D; Seidmon E J; Kennealey G T
Quality of life and psychosocial status in stage D prostate cancer. Zoladex Prostate Cancer Study Group.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 1992;1(5):323-9.
1992: Soloway M S; Patel J
Surgical techniques for endoscopic resection of bladder cancer.
The Urologic clinics of North America 1992;19(3):467-71.
1992: Newling D W; McLeod D; Soloway M; Di Silverio F; Smith P
Distant disease.
Cancer 1992;70(1 Suppl):365-7.
1992: Matzkin H; Soloway M S
Response to second-line hormonal manipulation monitored by serum PSA in stage D2 prostate carcinoma.
Urology 1992;40(1):78-80.
1992: Rangel C; Matzkin H; Soloway M S
Experience with weekly doxorubicin (adriamycin) in hormone-refractory stage D2 prostate cancer.
Urology 1992;39(6):577-82.
1992: Matzkin H; Rangel M C; Soloway M S
In vitro study of the effect of hyperthermia on normal bladder cell line and on five different transitional cell carcinoma cell lines.
The Journal of urology 1992;147(6):1671-4.
1992: Allen M; Wolfe J; Soloway M S
Local tumor recurrence following "radical prostatectomy".
Urology 1992;39(5):468-9.
1992: Matzkin H; Moinuddin S M; Soloway M S
Value of urine cytology versus bladder washing in bladder cancer.
Urology 1992;39(3):201-3.
1992: Splinter T A; Scher H I; Denis L; Bukowski R; Simon S; Klimberg I; Soloway M; Vogelzang N J; van Tinteren H; Herr H
The prognostic value of the pathological response to combination chemotherapy before cystectomy in patients with invasive bladder cancer. European Organization for Research on Treatment of Cancer--Genitourinary Group.
The Journal of urology 1992;147(3):606-8.
1992: Lamm D L; van der Meijden P M; Morales A; Brosman S A; Catalona W J; Herr H W; Soloway M S; Steg A; Debruyne F M
Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer.
The Journal of urology 1992;147(3):596-600.
1992: Kakizoe T; Friedell G H; Soloway M S; Suemasu K; Shimosato Y; Mukai K
Report of the 1991 International Meeting on Fundamental and Clinical Research in Urogenital Cancer.
Japanese journal of clinical oncology 1992;22(1):60-5.
1992: Soloway M S; Altwein J E
The management of incidental T1aG1 (TNM 1987) prostate cancer.
The Prostate. Supplement 1992;4():149-51.
1992: Matzkin H; Soloway M S; Rangel M C; Laddu A
Efficacy of terazosin in patients with benign prostatic hyperplasia.
European urology 1992;21(2):126-30.
1992: Soloway M S; Perito P E
Superficial bladder cancer: diagnosis, surveillance and treatment.
Journal of cellular biochemistry. Supplement 1992;16I():120-7.
1992: Matzkin H; Soloway M S
Immunohistochemical evidence of the existence and localization of aromatase in human prostatic tissues.
The Prostate 1992;21(4):309-14.
1991: Matzkin H; Soloway M S; Hardeman S
Transitional cell carcinoma of the prostate.
The Journal of urology 1991;146(5):1207-12.
1991: Murphy W M; Soloway M S; Barrows G H
Pathologic changes associated with androgen deprivation therapy for prostate cancer.
Cancer 1991;68(4):821-8.
1991: Brausi M; Soloway M S
Morbidity of modified pelvic lymphadenectomy and radiotherapy for prostatic cancer.
Urology 1991;37(4):297-300.
1991: Chodak G W; Vogelzang N J; Caplan R J; Soloway M; Smith J A
Independent prognostic factors in patients with metastatic (stage D2) prostate cancer. The Zoladex Study Group.
JAMA : the journal of the American Medical Association 1991;265(5):618-21.
1991: Soloway M S; Chodak G; Vogelzang N J; Block N L; Schellhammer P F; Smith J A; Scott M; Kennealey G; Gau T C
Zoladex versus orchiectomy in treatment of advanced prostate cancer: a randomized trial. Zoladex Prostate Study Group.
Urology 1991;37(1):46-51.
1990: Soloway M S; Murphy W M; Johnson D E; Farrow G M; Paulson D F; Garnick M B
Initial evaluation and response criteria for patients with superficial bladder cancer. Report of a workshop.
British journal of urology 1990;66(4):380-5.
1990: Soloway M S
Invasive bladder cancer: selection of primary treatment.
Seminars in oncology 1990;17(5):551-4.
1990: Sharifi R; Soloway M; Clayton M; Mounzer A; Strub M; Siami P; Lee M
'Acute on chronic' effect of depot leuprolide in patients with stage D2 cancer of prostate.
Anti-cancer drugs 1990;1(1):29-31.
1990: Soloway M S
The importance of prognostic factors in advanced prostate cancer.
Cancer 1990;66(5 Suppl):1017-21.
1990: Hardeman S W; Soloway M S
Urethral recurrence following radical cystectomy.
The Journal of urology 1990;144(3):666-9.
1990: Ramsey J C; Soloway M S
Instillation of bacillus Calmette-Guerin into the renal pelvis of a solitary kidney for the treatment of transitional cell carcinoma.
The Journal of urology 1990;143(6):1220-2.
1990: Brausi M; Blatnik A; Soloway M S
Dose response relationship of methotrexate in combination with cisplatin in murine bladder cancer.
Urology 1990;35(3):253-6.
1990: Sharifi R; Soloway M
Clinical study of leuprolide depot formulation in the treatment of advanced prostate cancer. The Leuprolide Study Group.
The Journal of urology 1990;143(1):68-71.
1990: Brausi M; Soloway M S
Morbidity of modified pelvic lymphadenectomy and external beam radiation therapy for prostatic cancer.
Progress in clinical and biological research 1990;357():145-9.
1990: Splinter T A; Scher H I; Denis L; Bukowski R; Soloway M; Vogelzang N; Klimberg I; Dalesio O; Herr H
The prognostic value of the pT-category after combination chemotherapy for patients with invasive bladder cancer who underwent cystectomy. EORTC-GU group.
Progress in clinical and biological research 1990;353():219-24.
1990: Soloway M S
The importance of pretreatment testosterone and other prognostic variables in the response to androgen deprivation therapy.
Progress in clinical and biological research 1990;350():141-8.
1990: Soloway M S
Current concepts in the management of superficial bladder cancer.
Archivos españoles de urología 1990;43 Suppl 2():115-21.
1990: Soloway M S
Follow up of patients receiving treatment for superficial bladder cancer with mitomycin C and BCG.
Progress in clinical and biological research 1990;350():71-9.
1989: Hardeman S W; Causey J Q; Hickey D P; Soloway M S
Transrectal ultrasound for staging prior to radical prostatectomy.
Urology 1989;34(4):175-80.
1989: Brausi M; Soloway M S
Progression and complications after external beam radiation therapy for carcinoma of prostate.
Urology 1989;34(3):115-9.
1989: Hardeman S W; Wake R W; Soloway M S
Two new techniques for evaluating prostate cancer. The role of prostate-specific antigen and transrectal ultrasound.
Postgraduate medicine 1989;86(2):197-8, 201, 204 passim.
1989: Brausi M; Hickey D P; Blatnik A F; Soloway M S
M-VAC regimen in murine bladder tumors.
Journal of chemotherapy (Florence, Italy) 1989;1(4 Suppl):1132-3.
1989: Soloway M S; Ishikawa S; van der Zwaag R; Todd B
Prognostic factors in patients with advanced prostate cancer.
Urology 1989;33(5 Suppl):53-6.
1989: Ishikawa S; Soloway M S; Van der Zwaag R; Todd B
Prognostic factors in survival free of progression after androgen deprivation therapy for treatment of prostate cancer.
The Journal of urology 1989;141(5):1139-42.
1989: Cassileth B R; Soloway M S; Vogelzang N J; Schellhammer P S; Seidmon E J; Hait H I; Kennealey G T
Patients' choice of treatment in stage D prostate cancer.
Urology 1989;33(5 Suppl):57-62.
1989: Irwin R; Zincke H; Droller M J; Prout G R; Soloway M S
Treatment modalities in superficial bladder cancer.
Seminars in urology 1989;7(1 Suppl 1):1-12.
1989: Soloway M S; Ishikawa S; Taylor T; Ezell G
M-VAC or MVC for the treatment of advanced transitional cell carcinoma: metastatic, induction, and adjuvant.
Journal of surgical oncology. Supplement 1989;1():40-5.
1989: Soloway M S
Should all superficial bladder tumors be treated with intravesical therapy?
Progress in clinical and biological research 1989;303():491-501.
1989: Soloway M
Treatment of early prostate cancer.
Hormone research 1989;32 Suppl 1():59-60; discussion 60-1.
1989: Soloway M S
Diagnosis and management of superficial bladder cancer.
Seminars in surgical oncology 1989;5(4):247-54.
1989: Soloway M S; Jordan A M; Murphy W M
Rationale for intravesical chemotherapy in the treatment and prophylaxis of superficial transitional cell carcinoma.
Progress in clinical and biological research 1989;310():215-36.
1988: Heney N M; Koontz W W; Barton B; Soloway M; Trump D L; Hazra T; Weinstein R S
Intravesical thiotepa versus mitomycin C in patients with Ta, T1 and TIS transitional cell carcinoma of the bladder: a phase III prospective randomized study.
The Journal of urology 1988;140(6):1390-3.
1988: Soloway M S
Intravesical therapy for bladder cancer.
The Urologic clinics of North America 1988;15(4):661-9.
1988: Soloway M S
Adenocarcinoma of the prostate. Stage-by-stage treatment alternatives.
Postgraduate medicine 1988;84(7):44-6, 51-5.
1988: Hickey D; Soloway M S
Does invasive bladder cancer differ between women and men?
Urology 1988;32(3):183-5.
1988: Hardeman S W; Perry A; Soloway M S
Transitional cell carcinoma of the prostate following intravesical therapy for transitional cell carcinoma of the bladder.
The Journal of urology 1988;140(2):289-92.
1988: Soloway M S
Urinary incontinence. Introduction.
Postgraduate medicine 1988;83(7):77.
1988: Soloway M S
Optical dilator to obviate blind urethral dilatation prior to endoscopic resections.
Urology 1988;31(5):427-8.
1988: Smith R A; Wake R; Soloway M S
Benign prostatic hyperplasia. Universal problem among aging men.
Postgraduate medicine 1988;83(6):79-85.
1988: Soloway M S
Introduction and overview of intravesical therapy for superficial bladder cancer.
Urology 1988;31(3 Suppl):5-16.
1988: Soloway M S; Hardeman S W; Hickey D; Raymond J; Todd B; Soloway S; Moinuddin M
Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan.
Cancer 1988;61(1):195-202.
1988: Hickey D; Cant J; Soloway M S
Failure of chemotherapy to prolong life in patients with metastatic prostate cancer who have failed androgen deprivation.
Urology 1988;31(1):38-40.
1988: Soloway M S
Incorporation of M-VAC combination chemotherapy in the treatment of patients with invasive and metastatic bladder cancer.
European urology 1988;14 Suppl 1():42.
1988: Soloway M S
Efficacy of buserelin in advanced prostate cancer and comparison with historical controls.
American journal of clinical oncology 1988;11 Suppl 1():S29-32.
1987: Soloway M S
Evaluation and management of patients with superficial bladder cancer.
The Urologic clinics of North America 1987;14(4):771-80.
1987: Hickey D P; Brausi M; Blatnik A F; Soloway M S
Comparison of single agent cisplatin and cisplatin containing combinations in treatment of murine bladder cancer.
Urology 1987;30(5):484-7.
1987: Shipley W U; Prout G R; Einstein A B; Coombs L J; Wajsman Z; Soloway M S; Englander L; Barton B A; Hafermann M D
Treatment of invasive bladder cancer by cisplatin and radiation in patients unsuited for surgery.
JAMA : the journal of the American Medical Association 1987;258(7):931-5.
1987: Soloway M S
Selecting initial therapy for bladder cancer.
Cancer 1987;60(3 Suppl):502-13.
1987: Soloway M S
Is there a role for induction therapy for locally advanced bladder cancer?
Urology 1987;29(6):577-83.
1987: Vaughn W; Hickey D; Milam W H; Soloway M
Radical cystectomy in presence of fused "cake" kidney.
Urology 1987;29(5):552-4.
1987: Soloway M S; Perry A
Bacillus Calmette-Guerin for treatment of superficial transitional cell carcinoma of the bladder in patients who have failed thiotepa and/or mitomycin C.
The Journal of urology 1987;137(5):871-3.
1987: Presant C A; Soloway M S; Klioze S S; Yakabow A; Presant S N; Mendez R G; Kennedy P S; Wyres M R; Naessig V L; Todd B
Buserelin treatment of advanced prostatic carcinoma. Long-term follow-up of antitumor responses and improved quality of life.
Cancer 1987;59(10):1713-6.
1987: McIntire T L; Soloway M S; Murphy W M
Nephrogenic adenoma.
Urology 1987;29(3):237-41.
1986: Friedell G H; Soloway M S; Hilgar A G; Farrow G M
Summary of workshop on carcinoma in situ of the bladder.
The Journal of urology 1986;136(5):1047-8.
1986: Hickey D; Todd B; Soloway M S
Pre-treatment testosterone levels: significance in androgen deprivation therapy.
The Journal of urology 1986;136(5):1038-40.
1986: Hickey D P; Soloway M S; Murphy W M
Selective urethrectomy following cystoprostatectomy for bladder cancer.
The Journal of urology 1986;136(4):828-30.
1986: Murphy W M; Emerson L D; Chandler R W; Moinuddin S M; Soloway M S
Flow cytometry versus urinary cytology in the evaluation of patients with bladder cancer.
The Journal of urology 1986;136(4):815-9.
1986: Soloway M S
Treatment of prostatic cancer. Newer forms of androgen deprivation.
Postgraduate medicine 1986;80(1):249-52, 257-8.
1986: Cant J D; Murphy W M; Soloway M S
Prognostic significance of urine cytology on initial follow-up after intravesical mitomycin C for superficial bladder cancer.
Cancer 1986;57(11):2119-22.
1986: Murphy W M; Blatnik A F; Shelton T B; Soloway M S
Carcinogenesis in mammalian urothelium: changes induced by non-carcinogenic substances and chronic indwelling catheters.
The Journal of urology 1986;135(4):840-4.
1986: Locke J R; Soloway M S; Evans J; Murphy W M
Osteogenic differentiation associated with x-ray therapy for adenocarcinoma of the prostate gland.
American journal of clinical pathology 1986;85(3):375-8.
1986: Aso Y; Anderson L; Soloway M; Bouffioux C; Chisholm G; Debruyne F; Kawai T; Kurth K H; Maru A; Straffon W G
Prognostic factors in superficial bladder cancer.
Progress in clinical and biological research 1986;221():257-69.
1986: Soloway M S; Kurth K H; Herr H; Huland H; Denis L; Suzuki K; Blandy J; Hisazumi H; Koontz W; Tsugawa R
Surgical techniques in the management of patients with superficial bladder cancer.
Progress in clinical and biological research 1986;221():123-32.
1985: Soloway M S
Treatment of superficial bladder cancer with intravesical mitomycin C: analysis of immediate and long-term response in 70 patients.
The Journal of urology 1985;134(6):1107-9.
1985: Presant C A; Soloway M S; Klioze S S; Kosola J W; Yakabow A L; Mendez R G; Kennedy P S; Wyres M R; Naessig V L; Ford K S
Buserelin as primary therapy in advanced prostatic carcinoma.
Cancer 1985;56(10):2416-9.
1985: Soloway M S
Overview of treatment of superficial bladder cancer.
Urology 1985;26(4 Suppl):18-26.
1985: Koontz W W; Heney N M; Soloway M S; Kluskens L; Hazra T A; Trump D L; Barton B
Mitomycin for patients who have failed on thiotepa. The National Bladder Cancer Group.
Urology 1985;26(4 Suppl):30-1.
1985: Niell H B; Herrod H G; Blatnik A F; Soloway M S
In vitro and in vivo activity of two second generation platinum analogs in murine bladder cancer.
The Journal of urology 1985;134(2):399-402.
1985: Soloway M S
Flexible cystourethroscopy: alternative to rigid instruments for evaluation of lower urinary tract.
Urology 1985;25(5):472-4.
1985: Soloway M S
Learning to integrate systemic chemotherapy into a treatment plan for patients with advanced bladder cancer.
The Journal of urology 1985;133(3):440-1.
1985: Niell H B; Soloway M S; Wood C A
Effect of concentration and time of drug exposure on clonal growth of murine bladder cancer.
Urology 1985;25(3):267-72.
1985: Hill D E; Ford K S; Soloway M S
Radical cystectomy and adjuvant chemotherapy.
Urology 1985;25(2):151-4.
1985: Rubin P; Murphy W M; Driver C; Mobley J D; Soloway M S
Nephrogenic adenoma.
Urology 1985;25(2):190-3.
1984: Soloway M S
Intravesical and systemic chemotherapy in the management of superficial bladder cancer.
The Urologic clinics of North America 1984;11(4):623-35.
1984: Soloway M S
Newer methods of hormonal therapy for prostate cancer.
Urology 1984;24(5 Suppl):30-8.
1984: Shipley W U; Coombs L J; Einstein A B; Soloway M S; Wajsman Z; Prout G R
Cisplatin and full dose irradiation for patients with invasive bladder carcinoma: a preliminary report of tolerance and local response.
The Journal of urology 1984;132(5):899-903.
1984: Morrison D A; Murphy W M; Ford K S; Soloway M S
Surveillance of stage O, grade I bladder cancer by cytology alone--is it acceptable?
The Journal of urology 1984;132(4):672-4.
1984: Walzer Y; Oswalt J; Soloway M S
Estramustine phosphate--hormone, chemotherapeutic agent, or both?
Urology 1984;24(1):53-8.
1984: Soloway M S
Superficial bladder cancer: comments on evaluation and management.
The Journal of urology 1984;132(1):91.
1984: Nag S; Blatnik A; Soloway M
Enhancement of high intensity Iodine-125 brachytherapy by cis-platinum in a murine bladder tumor model.
The Journal of urology 1984;131(6):1225-8.
1984: Hopkins S C; Buice R G; Matheny R; Soloway M S
The stability and antitumor activity of recycled (intravesical) mitomycin C.
Cancer 1984;53(10):2063-8.
1984: Niell H B; Soloway M S; Matheny R B; Blatnik A
Chemotherapy of murine bladder cancer: in vitro and in vivo.
Urology 1984;23(4 Suppl):124-8.
1984: Murphy W M; Soloway M S; Jukkola A F; Crabtree W N; Ford K S
Urinary cytology and bladder cancer. The cellular features of transitional cell neoplasms.
Cancer 1984;53(7):1555-65.
1984: Soloway M S; Niell H B; Matheny R B; Blatnik A
Systemic chemotherapy of murine bladder cancer.
Urology 1984;23(4 Suppl):129-34.
1984: Einstein A B; Shipley W; Coombs J; Cummings K B; Soloway M S; Hawkins I
Cisplatin as adjunctive treatment for invasive bladder carcinoma: tolerance and toxicities.
Urology 1984;23(4 Suppl):110-7.
1984: Soloway M S
Systemic therapy for superficial bladder cancer.
Urology 1984;23(4 Suppl):88-93.
1984: Issell B F; Prout G R; Soloway M S; Cummings K B; Brannen G; Veenema R; Flanagan M; Block N L; Summers J L; Levin E A
Mitomycin C intravesical therapy in noninvasive bladder cancer after failure on thiotepa.
Cancer 1984;53(5):1025-8.
1984: Maddux H B; Walzer Y; Holbert J M; West W; Soloway M S
Clinicopathological conference. Abdominal pain, left retroperitoneal mass and right renal mass in a 62-year-old man.
The Journal of urology 1984;131(2):320-3.
1984: Hopkins S C; Nag S K; Soloway M S
Primary carcinoma of male urethra.
Urology 1984;23(2):128-33.
1984: Akaza H; Koseki K; Kobayashi K; Niijima T; Soloway M S; Iwabuchi M; Muraoka Y
[Experimental intravesical treatment of bladder tumor with Concanavalin-A conjugated bleomycin]
Nippon Hinyokika Gakkai zasshi. The japanese journal of urology 1984;75(2):211-4.
1984: Hopkins S C; Palmieri G M; Niell H B; Moinuddin M; Soloway M S
Total and nondialyzable hydroxyproline excretion in Stage D2 prostate cancer.
Cancer 1984;53(1):117-21.
1984: Akaza H; Murphy W M; Soloway M S
Bladder cancer induced by noncarcinogenic substances.
The Journal of urology 1984;131(1):152-5.
1984: Soloway M S; Bicknell L
Role of selected mucosal biopsies in the evaluation of patients with bladder cancer.
Progress in clinical and biological research 1984;162A():275-81.
1984: Soloway M S
Rationale for intensive intravesical chemotherapy.
Progress in clinical and biological research 1984;153():287-95.
1983: Crabtree W N; Soloway M S; Matheny R B; Murphy W M
Metastatic characteristics of four FANFT-induced murine bladder tumors.
Urology 1983;22(5):529-31.
1983: Niell H B; Neely C L; Wood C A; Soloway M S; Maxwell T A; Buxton B H; Dilawari R A; Kim W S
Use of tumor colony assay in clinical oncology.
Southern medical journal 1983;76(11):1376-9.
1983: Soloway M S; Ford K S
Thiotepa-induced myelosuppression: review of 670 bladder instillations.
The Journal of urology 1983;130(5):889-91.
1983: Walzer Y; Soloway M S
Should the followup of patients with bladder cancer include routine excretory urography?
The Journal of urology 1983;130(4):672-3.
1983: Niell H B; Palmieri G M; Neely C L; Maxwell T A; Hopkins S C; Soloway M S
Total, dialyzable, and nondialyzable postabsorptive hydroxyproline. Values in patients with cancer.
Archives of internal medicine 1983;143(10):1925-7.
1983: Soloway M S; Einstein A; Corder M P; Bonney W; Prout G R; Coombs J
A comparison of cisplatin and the combination of cisplatin and cyclophosphamide in advanced urothelial cancer. A National Bladder Cancer Collaborative Group A Study.
Cancer 1983;52(5):767-72.
1983: Soloway M S
The plight of the cancer patient--the double-edged sword.
The Journal of urology 1983;130(2):349.
1983: Niell H B; Soloway M S; Wood C A; McCallum L W; Webster K
The use of a tumor colony assay in predicting chemotherapeutic drug response in murine bladder cancer.
Cancer 1983;52(4):619-25.
1983: Hopkins S C; Ford K S; Soloway M S
Invasive bladder cancer: support for screening.
The Journal of urology 1983;130(1):61-4.
1983: Soloway M S; Ford K S
Subsequent tumor analysis of 36 patients who have received intravesical mitomycin C for superficial bladder cancer.
The Journal of urology 1983;130(1):74-8.
1983: Gibbons R P; Beckley S; Brady M F; Chu T M; Dekernion J B; Dhabuwala C; Gaeta J F; Loening S A; McKiel C F; McLeod D G; Pontes J E; Prout G R; Scardino P T; Schlegel J U; Schmidt J D; Scott W W; Slack N H; Soloway M S; Murphy G P
The addition of chemotherapy to hormonal therapy for treatment of patients with metastatic carcinoma of the prostate.
Journal of surgical oncology 1983;23(2):133-42.
1983: Niell H B; Soloway M S
Use of the tumour colony assay in the evaluation of patients with bladder cancer.
British journal of urology 1983;55(3):271-4.
1983: Hopkins S C; Vider M; Nag S K; Tai D L; Soloway M S
Carcinoma of the female urethra: reassessment of modes of therapy.
The Journal of urology 1983;129(5):958-61.
1983: Loening S A; Beckley S; Brady M F; Chu T M; deKernion J B; Dhabuwala C; Gaeta J F; Gibbons R P; McKiel C F; McLeod D G; Pontes J E; Prout G R; Scardino P T; Schlegel J U; Schmidt J D; Scott W W; Slack N H; Soloway M S; Murphy G P
Comparison of estramustine phosphate, methotrexate and cis-platinum in patients with advanced, hormone refractory prostate cancer.
The Journal of urology 1983;129(5):1001-6.
1983: Murphy G P; Beckley S; Brady M F; Chu T M; deKernion J B; Dhabuwala C; Gaeta J F; Gibbons R P; Loening S A; McKiel C F; McLeod D G; Pontes J E; Prout G R; Scardino P T; Schlegel J U; Schmidt J D; Scott W W; Slack N H; Soloway M S
Treatment of newly diagnosed metastatic prostate cancer patients with chemotherapy agents in combination with hormones versus hormones alone.
Cancer 1983;51(7):1264-72.
1983: Akaza H; Crabtree W N; Matheny R B; Soloway M S
Chemoimmunotherapy of implanted murine bladder cancer.
Urology 1983;21(3):273-6.
1983: Soloway M S
Bladder cancer. Management of an increasingly common tumor.
Postgraduate medicine 1983;73(3):139-51.
1983: Hopkins S C; Nissenkorn I; Palmieri G M; Ikard M; Moinuddin M; Soloway M S
Serial spot hydroxyproline/creatinine ratios in metastatic prostatic cancer.
The Journal of urology 1983;129(2):319-23.
1983: Soloway M S
Surgery and intravesical chemotherapy in the management of superficial bladder cancer.
Seminars in urology 1983;1(1):23-33.
1983: Soloway M S; Nissenkorn I; McCallum L
Urothelial susceptibility to tumor cell implantation: comparison of cauterization with N-methyl-N-nitrosourea.
Urology 1983;21(2):159-61.
1983: Soloway M S; Beckley S; Brady M F; Chu T M; deKernion J B; Dhabuwala C; Gaeta J F; Gibbons R P; Loening S A; McKiel C F; McLeod D G; Pontes J E; Prout G R; Scardino P T; Schlegel J U; Schmidt J D; Scott W W; Slack N H; Murphy G P
A comparison of estramustine phosphate versus cis-platinum alone versus estramustine phosphate plus cis-platinum in patients with advanced hormone refractory prostate cancer who had had extensive irradiation to the pelvis or lumbosacral area.
The Journal of urology 1983;129(1):56-61.
1983: Kyriazis A A; Kyriazis A P; Kereiakes J G; Soloway M S; McCombs W B
Histopathologic evaluation of response to treatment of human tumors grown in the nude mouse.
Experimental cell biology 1983;51(2):83-95.
1982: Soloway M S; Ikard M; Scheinberg M; Evans J
Concurrent radiation and cisplatin in the treatment of advanced bladder cancer: a preliminary report.
The Journal of urology 1982;128(5):1031-3.
1982: Hopkins S C; Matheny R; Soloway M S
Systemic mitomycin C versus cisplatin: comparison of antitumor activity in primary murine bladder cancer.
Urology 1982;20(2):157-9.
1982: Nissenkorn I; Mickey D D; Soloway M S
Effect of media and growth promoters on in vitro cultivation of normal murine urinary bladder epithelium.
The Journal of urology 1982;128(1):176-9.
1982: Mickey D D; Mickey G H; Murphy W M; Niell H B; Soloway M S
In vitro characterization of four N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide (FANFT) induced mouse bladder tumors.
The Journal of urology 1982;127(6):1233-7.
1982: Nissenkorn I; Mickey D D; Miller D B; Soloway M S
Circadian and day-to-day variation of prostatic acid phosphatase.
The Journal of urology 1982;127(6):1122-4.
1982: Murphy W M; Soloway M S
Urothelial dysplasia.
The Journal of urology 1982;127(5):849-54.
1982: Niell H B; Soloway M S; Nissenkorn I
The clonogenic growth of cells derived from bladder barbotage in patients with transitional cell carcinoma of the bladder: a preliminary report.
The Journal of urology 1982;127(4):668-70.
1982: Niell H B; Wood C A; Mickey D D; Soloway M S
Time- and concentration-dependent inhibition of the clonogenic growth of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced murine bladder tumor cell lines by cis-diamminedichloroplatinum(II).
Cancer research 1982;42(3):807-11.
1982: Soloway M S; Nissenkorn I; McCallum L W; Murphy W M
Single and sequential combination intravesical chemotherapy of murine bladder cancer.
Urology 1982;19(2):169-75.
1982: Niell H B; Mickey D D; Soloway M S; Wood C A
Growth characteristics of N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide (FANFT)-induced mouse bladder tumor lines in a human tumor stem cell assay.
Cancer 1982;49(2):323-30.
1982: Buice R G; Soloway M S
Platinum kinetics in patients treated with cis-dichlorodiammine platinum (II).
Therapeutic drug monitoring 1982;4(3):293-6.
1982: Murphy W M; Soloway M S
Developing carcinoma (dysplasia) of the urinary bladder.
Pathology annual 1982;17 (Pt 1)():197-217.
1981: Soloway M S; Nissenkorn I; McCallum L W
Comparison between a purified and standard diet on FANFT-induced murine bladder cancer.
Urology 1981;18(5):482-4.
1981: Nissenkorn I; Herrod H; Soloway M S
Side effects associated with intravesical mitomycin.
The Journal of urology 1981;126(5):596-7.
1981: Murphy W M; Soloway M S; Finebaum P J
Pathological changes associated with topical chemotherapy for superficial bladder cancer.
The Journal of urology 1981;126(4):461-4.
1981: Murphy W M; Crabtree W N; Jukkola A F; Soloway M S
The diagnostic value of urine versus bladder washing in patients with bladder cancer.
The Journal of urology 1981;126(3):320-2.
1981: Nissenkorn I; McCallum L; Crabtree W N; Murphy W M; Soloway M S
Evaluation of cystography for detection of bladder carcinoma in mice: comparison with urinary cytology.
Urology 1981;18(1):68-71.
1981: Loening S A; Scott W W; deKernion J; Gibbons R P; Johnson D E; Pontes J E; Prout G R; Schmidt J D; Soloway M S; Chu T M; Gaeta J F; Slack N H; Murphy G P
A comparison of hydroxyurea, methyl-chloroethyl-cyclohexy-nitrosourea and cyclophosphamide in patients with advanced carcinoma of the prostate.
The Journal of urology 1981;125(6):812-6.
1981: Murphy W M; Soloway M S; Crabtree W N
The morphologic effects of mitomycin C in mammalian urinary bladder.
Cancer 1981;47(11):2567-74.
1981: Soloway M S; deKernion J B; Gibbons R P; Johnson D E; Loening S A; Pontes J E; Prout G R; Schmidt J D; Scott W W; Chu T M; Gaeta J F; Slack N H; Murphy G P
Comparison of estramustine phosphate and vincristine alone or in combination for patients with advanced, hormone refractory, previously irradiated carcinoma of the prostate.
The Journal of urology 1981;125(5):664-7.
1981: Soloway M S; Murphy W M; DeFuria M D; Crooke S; Finebaum P
The effect of mitomycin C on superficial bladder cancer.
The Journal of urology 1981;125(5):646-8.
1981: Alabaster A M; Jordan W P; Soloway M S; Shippel R M; Young J M
Leiomyosarcoma of the bladder and subsequent urethral recurrence.
The Journal of urology 1981;125(4):583-5.
1981: Soloway M S; Ikard M; Ford K
Cis-diamminedichloroplatinum (II) in locally advanced and metastatic urothelial cancer.
Cancer 1981;47(3):476-80.
1980: Buice R G; Soloway M S
Potential effects of edema on the pharmacokinetics of platinum in patients treated with cis-dichlorodiammine platinum (II).
Research communications in chemical pathology and pharmacology 1980;30(3):447-57.
1980: Shippel R M; Sacks H S; Soloway M S
Case report: Primary hyperparathyroidism coincident with metastatic carcinoma of the prostate.
Journal of the Tennessee Medical Association 1980;73(11):803-4.
1980: Soloway M S; Masters S
Urothelial susceptibility to tumor cell implantation: influence of cauterization.
Cancer 1980;46(5):1158-63.
1980: Soloway M S
Bladder cancer--Part III.
The Journal of urology 1980;124(1):47.
1980: Raghavaiah N V; Mayer R F; Hagitt R; Soloway M S
Malignant fibrous histiocytoma of the kidney.
The Journal of urology 1980;123(6):951-3.
1980: Soloway M S
The management of superficial bladder cancer.
Cancer 1980;45(7 Suppl):1856-65.
1980: Soloway M S
Rationale for intensive intravesical chemotherapy for superficial bladder cancer.
The Journal of urology 1980;123(4):461-6.
1980: Schmidt J D; Scott W W; Gibbons R; Johnson D E; Prout G R; Loening S; Soloway M; deKernion J B; Pontes J E; Slack N H; Murphy G P
Chemotherapy programs of the National Prostatic Cancer Project (NPCP).
Cancer 1980;45(7 Suppl):1937-46.
1980: Murphy W M; Soloway M S
The effect of thio-TEPA on developing and established mammalian bladder tumors.
Cancer 1980;45(5):870-5.
1980: DeFuria M D; Bracken R B; Johnson D E; Soloway M S; Merrin C E; Morgan L R; Miller H C; Crooke S T
Phase I-II study of mitomycin C topical therapy for low-grade, low stage transitional cell carcinoma of the bladder: an interim report.
Cancer treatment reports 1980;64(2-3):225-30.
1980: Daskal Y; Soloway M S; DeFuria M D; Crooke S T
Morphological effects of mitomycin C administered intravesically to normal mice and mice with N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide-induce bladder neoplasms.
Cancer research 1980;40(2):261-7.
1980: Rao M K; Soloway M S
Medroxyprogesterone in metastatic renal cell carcinoma.
Southern medical journal 1980;73(2):247-8.
1980: Brock J; Soloway M S
Retroperitoneal fibrosis and aortic aneurysm.
Urology 1980;15(1):14-6.
1979: Soloway M S; Shippel R M; Ikard M
Cyclophosphamide, doxorubicin hydrochloride and 5-fluorouracil in advanced carcinoma of the prostate.
The Journal of urology 1979;122(5):637-9.
1979: Murphy W M; Nagy G K; Rao M K; Soloway M S; Parija G C; Cox C E; Friedell G H
"Normal" urothelium in patients with bladder cancer: a preliminary report from the National Bladder Cancer Collaborative Group A.
Cancer 1979;44(3):1050-8.
1979: Soloway M S; Morris C R; Sudderth B
Radiation Therapy and cis-diammine-dichloroplatinum (II) in transplantable and primary murine bladder cancer.
International journal of radiation oncology, biology, physics 1979;5(8):1355-60.
1979: Murphy G P; Gibbons R P; Johnson D E; Prout G R; Schmidt J D; Soloway M S; Loening S A; Chu T M; Gaeta J F; Saroff J; Wajsman Z; Slack N; Scott W W
The use of estramustine and prednimustine versus prednimustine alone in advanced metastatic prostatic cancer patients who have received prior irradiation.
The Journal of urology 1979;121(6):763-5.
1979: Soloway M S; Murphy W M
Experimental chemotherapy of bladder cancer--systemic and intravesical.
Seminars in oncology 1979;6(2):166-83.
1979: Soloway M S
Re: serial multiple-site biopsies in patients with bladder cancer.
The Journal of urology 1979;121(4):545.
1979: Collier M D; Jerkins G R; Noe H N; Soloway M S
Proximal stent displacement as complication of pigtail ureteral stent.
Urology 1979;13(4):372-5.
1979: Schmidt J D; Scott W W; Gibbons R P; Johnson D E; Prout G R; Loening S A; Soloway M S; Chu T M; Gaeta J F; Slack N H; Saroff J; Murphy G P
Comparison of procarbazine, imidazole-carboxamide and cyclophosphamide in relapsing patients with advanced carcinoma of the prostate.
The Journal of urology 1979;121(2):185-9.
1979: Soloway M S; Cox C E
The effect of platinum analogues and combination chemotherapy on murine bladder cancer.
Transactions of the American Association of Genito-Urinary Surgeons 1979;71():8-13.
1978: Soloway M S
Effectiveness of long-term chemotherapy and/or BCG on murine bladder cancer.
National Cancer Institute monograph 1978;(49):327-32.
1978: Soloway M S; Martino C; Hyatt C; Marrone J C
Immunogenicity of N-[-4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced bladder cancer.
National Cancer Institute monograph 1978;(49):293-300.
1978: Soloway M S; Ikard M; Tidwell M
Role of nurse clinician in urologic oncology.
Urology 1978;12(6):685-8.
1978: Soloway M S
Cis-diamminedichloroplatinum II in advanced urothelial cancer.
The Journal of urology 1978;120(6):716-9.
1978: Murphy W M; Soloway M S; Lin C J
Morphologic effects of thio-TEPA on mammalian urothelium. Changes in abnormal cells.
Acta cytologica 1978;22(6):550-4.
1978: Soloway M S; Murphy W; Rao M K; Cox C
Serial multiple-site biopsies in patients with bladder cancer.
The Journal of urology 1978;120(1):57-9.
1978: Pearson R M; Soloway M S
Does cyclophosphamide induce bladder cancer?
Urology 1978;11(5):437-47.
1978: Morrow T W; Soloway M S
Re: embryonal carcinoma of the testis in elderly men.
The Journal of urology 1978;119(5):709-10.
1978: Murphy G P; Gibbons R P; Johnson D E; Prout G R; Schmidt J D; Soloway M S; Loening S A; Chu T M; Gaeta J F; Saroff J; Wajsman Z; Slack N; Scott W W
The use of estramustine and prednimustine versus prednimustine alone in advanced metastatic prostatic cancer patients who have received prior irradiation.
Transactions of the American Association of Genito-Urinary Surgeons 1978;70():69-71.
1977: Raghavaiah N V; Soloway M S; Murphy W M
Malignant penile horn.
The Journal of urology 1977;118(6):1068-9.
1977: Murphy W M; Vandevoorde J P; Rao M K; Soloway M S
The clinical value of urinary carcinoembryonic antigen-like substances in urothelial cancer.
The Journal of urology 1977;118(5):806-8.
1977: Raghavaiah N V; Soloway M S
Anuria following silver nitrate irrigation for intractable bladder hemorrhage.
The Journal of urology 1977;118(4):681-2.
1977: Murphy W M; Soloway M S; Lin C J
Morphologic effects of thio-TEPA on mouse urothelium.
Acta cytologica 1977;21(5):701-4.
1977: Soloway M S
Intravesical and systemic chemotherapy of murine bladder cancer.
Cancer research 1977;37(8 Pt 2):2918-29.
1977: Soloway M S; Rao M K; Kest L
Hematocolpos with urinary tract obstruction in an adult.
The Journal of urology 1977;117(6):811-2.
1977: Soloway M S; Gehrki G
Radiation therapy of experimental murine bladder cancer - synergism with cisplatinum diamminedichloride.
Surgical forum 1977;28():559-61.
1976: Soloway M S; Herman G; Guerrier K; Persky L
Case profile: horseshoe kidney with calculi in patient with sarcoidosis.
Urology 1976;8(6):608-9.
1976: Soloway M S
FANFT-induced bladder tumors.
Urology 1976;8(5):520.
1976: Collier D; Soloway M S
Doxorubicin hydrochloride, cyclophosphamide, and 5-fluorouracil combination in advanced prostate and transitional cell carcinoma.
Urology 1976;8(5):459-64.
1976: Pendergrast W J; Soloway M S; Myers G H; Futrell J W
Regional lymphadenectomy and tumor immunity.
Surgery, gynecology & obstetrics 1976;142(3):385-90.
1976: Soloway M S; Martino C
Prophylaxis of bladder tumor implantation. Intravesical and systemic chemotherapy.
Urology 1976;7(1):29-34.
1975: Soloway M S
Single and combination chemotherapy for primary murine bladder cancer.
Cancer 1975;36(2):333-40.
1975: Weldon T E; Soloway M S
Susceptibility of urothelium to neoplastic cellular implantation.
Urology 1975;5(6):824-7.
1975: Rudolph R; Soloway M; DePalma R G; Persky L
Fournier's syndrome: synergistic gangrene of the scrotum.
American journal of surgery 1975;129(5):591-6.
1975: Soloway M S; Cohen S M; Dekernion J B; Persky L
Failure of ascorbic acid to inhibit FANFT-induced bladder cancer.
The Journal of urology 1975;113(4):483-6.
1974: Soloway M S; Myers G H; Krueger G
Lymphocytic reaction associated with bladder cancer. Effect of chronic immunosuppression.
Urology 1974;3(4):437-43.
1974: Weldon T E; Soloway M S; Persky L
Urothelial susceptibility to neoplastic cellular implantation.
Surgical forum 1974;25(0):547-9.
1973: Soloway M S; Myers G H
The effect of hormonal therapy on a transplantable renal cortical adenocarcinoma in syngeneic mice.
The Journal of urology 1973;109(3):356-61.
1973: Soloway M S; Myers G H; Marrone J A; Del Vecchio P R; Malmgren R A
Evaluation of urinary cytology as an indicator of bladder neoplasia in mice.
The Journal of urology 1973;109(2):249-52.
1973: Soloway M S; deKernion J B; Rose D; Persky L
Effect of chemotherapeutic agents on bladder cancer: a new animal model.
Surgical forum 1973;24():542-4.
1972: Shimkin P M; Soloway M S; Jaffe E
Metastatic melanoma of the gallbladder.
The American journal of roentgenology, radium therapy, and nuclear medicine 1972;116(2):393-5.
1972: Soloway M S; Myers G H; Johnston G; Ketcham A S
Renography in the evaluation of patients with ileal conduits.
Surgery, gynecology & obstetrics 1972;135(4):521-4.
1972: Soloway M S; Myers G H; Larsen S; Johnston G
Radioisotope renography in patients with an ileal conduit: the importance of the sitting position.
The Journal of urology 1972;108(2):202-4.
1972: Soloway M S; Larson S M; Myers G H
Evidence against a vesicorenal reflex.
The Journal of urology 1972;107(5):751-4.
1972: Shimkin P M; Buchignani J S; Soloway M S
Blood borne metastases to the kidney. Angiographic investigation of three vascular tumors.
Acta radiologica: diagnosis 1972;12(3):387-95.
1972: Soloway M S; Myers G H; Burdick J F; Malmgren R A
Ileal conduit exfoliative cytology in the diagnosis of recurrent cancer.
The Journal of urology 1972;107(5):835-9.
1972: Soloway M S; Larson S M; Myers G H; Johnston G S; Ketcham A S
Value of renography following radical pelvic cancer surgery.
Journal of surgical oncology 1972;4(4):306-19.
1972: Soloway M S; Pendergrast W J; Myers G H
Effect of regional lymphadenectomy on development of concomitant immunity.
Surgical forum 1972;23(0):101-2.
1971: Malmgren R A; Soloway M S; Chu E W; Del Vecchio P R; Ketcham A S
Cytology of ileal conduit urine.
Acta cytologica 1971;15(5):506-9.
1971: Soloway M; Moriarty G; Fraser J G; White R J
Effect of delayed hyperventilation on experimental cerebral infarction.
Neurology 1971;21(5):479-85.
1970: Soloway M; Moriarty G; Fraser J G; White R J
The effect of delayed hyperventilation and experimental middle cerebral occlusion.
Neurology 1970;20(4):417.
1970: Soloway M; Moir T W; Linton D S
Takayasu's arteritis. Report of a case with unusual findings.
The American journal of cardiology 1970;25(2):258-63.
1970: Soloway M; Moriarty G; White R J
Delayed hyperventilation in the treatment of experimental cerebral vascular occlusion.
Surgical forum 1970;21():423-5.
1968: Soloway M; Nadel W; Albin M S; White R J
The effect of hyperventilation on subsequent cerebral infarction.
Anesthesiology 1968;29(5):975-80.

Sign-in to see more